Skip to main content
34°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bluebird Bio
(NQ:
BLUE
)
6.340
+5.960 (+1568.42%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bluebird Bio
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
(BLUE) - Analyzing bluebird bio's Short Interest
February 29, 2024
Via
Benzinga
Beam Rockets 27%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug
February 27, 2024
Both companies are working on treatments for genetic disorders.
Via
Investor's Business Daily
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 27, 2024
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.
Via
Benzinga
Why Bluebird Bio Stock Is Tumbling Tuesday
December 19, 2023
Bluebird Bio Inc (NASDAQ: BLUE) shares are trading lower Tuesday after the company announced a proposed offering.
Via
Benzinga
If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today
January 27, 2024
The answer hardly inspires confidence.
Via
The Motley Fool
Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule
January 17, 2024
FDA approves CRISPR Therapeutics/Vertex's Casgevy a gene-edited cell therapy for transfusion-dependent beta-thalassemia. Vertex's swift launch strategy targets a network of treatment centers across the...
Via
Benzinga
Exposures
Product Safety
2 Red Flags for Bluebird Bio Stock
January 10, 2024
The biotech's struggles may continue.
Via
The Motley Fool
Better Risky Investment: Bluebird Bio vs. Shiba Inu
January 03, 2024
Few investors dare to tread where the ice is known to be very thin.
Via
The Motley Fool
Should You Invest in Bluebird Bio Right Now?
December 26, 2023
After two December share price crashes, there's no evident cure for Bluebird Bio's ills.
Via
The Motley Fool
If You Invested $10,000 in Bluebird Bio In 2021, This Is How Much You Would Have Today
December 24, 2023
Can things get better for this struggling stock?
Via
The Motley Fool
1 Green Flag and 1 Red Flag for Bluebird Bio Stock
December 23, 2023
The stock has been in the news lately.
Via
The Motley Fool
3 Money-Saving Tricks for Investing in Biotech Stocks in 2024
December 22, 2023
Doing a little math and doing a little extra research can make a big difference.
Via
The Motley Fool
Up More Than 60% in 2023, Is It Too Late to Buy This Soaring Biotech Stock?
December 22, 2023
The FDA's recent approval of CRISPR Therapeutics' first therapy is a step in the right direction.
Via
The Motley Fool
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 21, 2023
Via
Benzinga
S&P 500 Edges Lower; General Mills Cuts Sales Forecast
December 20, 2023
U.S. stocks traded mixed toward the end of trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.07% to 37,586.02 while the NASDAQ rose 0.17% to 15,029.36. The S&P 500, however,...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 20, 2023
Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 20, 2023
Via
Benzinga
Crude Oil Rises 1%; US Current Account Gap Narrows In Q3
December 20, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 20 points on Wednesday. The Dow traded up 0.06% to 37,581.68 while the NASDAQ rose 0.23% to 15,038.40. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
US Stocks Mostly Lower; FedEx Earnings Miss Estimates
December 20, 2023
U.S. stocks traded mostly lower this morning, with the Dow Jones index falling around 75 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.21% to 37,480.08 while the...
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Why Bluebird Bio Shares Are Getting Crushed Wednesday
December 20, 2023
Bluebird Bio Inc (NASDAQ: BLUE) shares are tanking Wednesday after the company announced the pricing of a $125 million public offering of common stock<
Via
Benzinga
Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
December 20, 2023
Shares of Aclarion, Inc. (NASDAQ: ACON) shares rose sharply in pre-market trading after the company was granted U.S. patent #11844601 for "MR SPECTROSCOPY SYSTEM FOR DIAGNOSING PAINFUL AND NON-PAINFUL...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 20, 2023
Via
Benzinga
FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
December 20, 2023
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 30 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 19, 2023
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 19, 2023
Via
Benzinga
Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday
December 19, 2023
U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday. Shares of bluebird bio, Inc. (NASDAQ: BLUE) shares fell sharply during Tuesday’s session after the company...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Motus GI Holdings Shares Are Trading Lower By Around 46%; Here Are 20 Stocks Moving Premarket
December 19, 2023
Shares of Motus GI Holdings, Inc. (NASDAQ: MOTS) shares fell sharply in pre-market trading after the company priced its $5 million public offering. Motus GI Holdings shares dipped 46.5% to $1.15 in...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 19, 2023
It's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning!
Via
InvestorPlace
Why Bluebird Bio Stock Tanked After-Hours
December 18, 2023
Bluebird bio, Inc. (NASDAQ: BLUE) shares are trading lower in Monday's after-hours session after the company announced a proposed public offering of $150 million
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 18, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.